The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation

被引:47
|
作者
Kwun, Hyun Jin [1 ]
da Silva, Suzane Ramos [1 ,2 ]
Qin, Huilian [3 ]
Ferris, Robert L. [1 ,4 ,5 ,6 ]
Tan, Rusung [3 ]
Chang, Yuan [1 ]
Moore, Patrick S. [1 ]
机构
[1] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA 15213 USA
[2] Sao Paulo State Univ, Botucatu Sch Med, Dept Pathol, Sao Paulo, Brazil
[3] Univ British Columbia, British Columbia Childrens Hosp, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
[4] Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Pittsburgh, PA 15213 USA
[5] Univ Pittsburgh, Med Ctr, Dept Immunol, Pittsburgh, PA 15213 USA
[6] Univ Pittsburgh, Inst Canc, Canc Immunol Program, Pittsburgh, PA 15213 USA
关键词
Kaposi's sarcoma-associated herpesvirus; Latency-associated nuclear antigen 1; Major histocompatibility complex class I; Immune evasion; DNA-SEQUENCES; IMMUNE EVASION; VIRUS; IDENTIFICATION; INHIBITION; GLYCOPROTEIN; AIDS; TRANSLATION; TRANSPORTER; PERSISTENCE;
D O I
10.1016/j.virol.2011.01.026
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
KSHV LANA1, a latent protein expressed during chronic infection to maintain a viral genome, inhibits major histocompatibility complex class I (MHCI) peptide presentation in cis as a means of immune evasion. Through deletional cloning, we localized this function to the LANA1 central repeat 1 (CR1) subregion. Other CR subregions retard LANA1 translation and proteasomal processing but do not markedly inhibit LANA1 peptide processing by MHC I. Inhibition of proteasomal processing ablates LANA1 peptide presentation. Direct expression of LANA1 within the endoplasmic reticulum (ER) overcomes CR1 inhibition suggesting that CR1 acts prior to translocation of cytoplasmic peptides into the ER. By physically separating CR1 from other subdomains, we show that LANA1 evades MHC I peptide processing by a mechanism distinct from other herpesviruses including Epstein-Barr virus (EBV). Although LANA1 and EBV EBNA1 are functionally similar, they appear to use different mechanisms to evade host cytotoxic T lymphocyte surveillance. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:357 / 365
页数:9
相关论文
共 50 条
  • [31] Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes
    Host, Kurtis M.
    Jacobs, Sarah R.
    West, John A.
    Zhang, Zhigang
    Costantini, Lindsey M.
    Stopford, Charles M.
    Dittmer, Dirk P.
    Damania, Blossom
    MBIO, 2017, 8 (05):
  • [32] High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population
    Feiterna-Sperling, Cornelia
    Koenigs, Christoph
    Notheis, Gundula
    Buchholz, Bernd
    Krueger, Renate
    Weizsaecker, Katharina
    Eberle, Josef
    Hanhoff, Nikola
    Gaertner, Barbara
    Heider, Harald
    Krueger, Detlev H.
    Hofmann, Joerg
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2016, 205 (05) : 425 - 434
  • [33] Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis
    Pringle, Eric S.
    Robinson, Carolyn-Ann
    McCormick, Craig
    JOURNAL OF VIROLOGY, 2019, 93 (21)
  • [34] Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus
    Chang, Pey-Jium
    Chen, Lee-Wen
    Shih, Yan-Chung
    Tsai, Ping-Hsin
    Liu, An-Chi
    Hung, Chien-Hui
    Liou, Jieh-Yuan
    Wang, Shie-Shan
    VIROLOGY, 2011, 413 (02) : 194 - 204
  • [35] Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex
    Roupelieva, Maria
    Griffiths, Samantha J.
    Kremmer, Elisabeth
    Meisterernst, Michael
    Viejo-Borbolla, Abel
    Schulz, Thomas
    Haas, Juergen
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 1138 - 1149
  • [36] A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma
    Bonsignore, L.
    Passelli, K.
    Pelzer, C.
    Perroud, M.
    Konrad, A.
    Thurau, M.
    Sturzl, M.
    Dai, L.
    Trillo-Tinoco, J.
    Del Valle, L.
    Qin, Z.
    Thome, M.
    LEUKEMIA, 2017, 31 (03) : 614 - 624
  • [37] Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Reduces Interleukin-8 Expression in Endothelial Cells and Impairs Neutrophil Chemotaxis by Degrading Nuclear p65
    Li, Xiaofan
    Liang, Deguang
    Lin, Xianzhi
    Robertson, Erle S.
    Lan, Ke
    JOURNAL OF VIROLOGY, 2011, 85 (17) : 8606 - 8615
  • [38] Kaposi's Sarcoma-Associated Herpesvirus ORF45 Mediates Transcriptional Activation of the HIV-1 Long Terminal Repeat via RSK2
    Karijolich, John
    Zhao, Yang
    Peterson, Bret
    Zhou, Qiang
    Glaunsinger, Britt
    JOURNAL OF VIROLOGY, 2014, 88 (12) : 7024 - 7035
  • [39] Glutamate Secretion and Metabotropic Glutamate Receptor 1 Expression during Kaposi's Sarcoma-Associated Herpesvirus Infection Promotes Cell Proliferation
    Veettil, Mohanan Valiya
    Dutta, Dipanjan
    Bottero, Virginie
    Bandyopadhyay, Chirosree
    Gjyshi, Olsi
    Sharma-Walia, Neelam
    Dutta, Sujoy
    Chandran, Bala
    PLOS PATHOGENS, 2014, 10 (10)
  • [40] Kaposi's sarcoma-associated herpesvirus promotes mesenchymal-to-endothelial transition by resolving the bivalent chromatin of PROX1 gene
    Ding, Yao
    Chen, Weikang
    Lu, Zhengzhou
    Wang, Yan
    Yuan, Yan
    PLOS PATHOGENS, 2021, 17 (09)